(MENAFN- GlobeNewsWire - Nasdaq) Growing Adoption of Electronic Health Records, AI-Powered Clinical Documentation, and Generative AI Applications in Drug Discovery Drives Global Market Expansion. Copy Sub-HeadlineBurlingame, CA, Nov. 16, 2026 (GLOBE NEWSWIRE) -- The Global Generative AI in Healthcare Market is estimated to be valued at USD 3.86 billion in 2026 and is projected to reach USD 19.72 billion by 2033, registering a compound annual growth rate (CAGR) of 26.2% during 2026–2033. Market growth is primarily driven by the widespread adoption of electronic health records (EHRs), which provide extensive clinical datasets for training and deploying generative AI models, increasing demand for AI-powered healthcare solutions, and growing investments in healthcare digitalization. Additionally, advancements in large language models (LLMs), rising adoption of AI-assisted clinical documentation, increasing applications in medical imaging and drug discovery, and growing demand for personalized treatment solutions are supporting the expansion of the global generative AI in healthcare market.
Request Sample Report:

Global Generative AI In Healthcare Market Key Takeaways
According to Coherent Market Insights (CMI), the global generative AI in healthcare market is estimated at USD 3.86 billion in 2026 and is projected to reach USD 19.72 billion by 2033, registering a CAGR of 26.2% during the forecast period.
Based on component, software segment is projected to account for the largest revenue share of 74.3% in 2026 as healthcare organizations increasingly adopt AI platforms for clinical documentation, drug discovery, and workflow automation.
By application, drug discovery and development segment is slated to hold 31.8% of the global generative AI in healthcare market share in 2026, owing to growing use of AI models for drug target identification and molecular design.
Pharmaceutical and biotechnology companies are projected to account for a leading market share of 38.6% in 2026 because of rising investments in AI-supported research and drug development.
North America is expected to dominate the global market with a 42.7% share in 2026, owing to its established digital healthcare infrastructure, strong presence of technology companies as well as growing adoption of AI solutions.
Asia Pacific, with an estimated market contribution of 21.9% in 2026, is poised to emerge as the fastest-growing regional market during the forecast period, supported by increasing investments in healthcare technology and AI-based research.
Rapid Adoption of Generative AI in Clinical Workflows Driving Market Growth
Coherent Market Insights' latest generative AI in healthcare market analysis outlines major factors spurring industry growth. These include rapid adoption of generative AI for clinical workflow automation, growing investment in AI-enabled drug discovery as well as increasing use of digital healthcare technologies.
Growing adoption of generative AI among hospitals and healthcare providers is providing a strong impetus for market growth. Healthcare organizations in the contemporary world are increasingly using AI tools to prepare clinical notes, summarize patient records, assist with medical documentation, and automate routine administrative tasks. These applications can reduce the time healthcare professionals spend on paperwork and help them focus more on patient care.
For instance, Google Cloud launched its Gemini for Healthcare solution in November 2026. The healthcare-specific AI solution is designed to connect clinical, operational, and administrative information and support tasks such as medical record summarization and pre-appointment preparation. Such developments highlight growing interest in healthcare-specific generative AI solutions.
In addition, widespread adoption of electronic health records (EHRs) is providing access to digital clinical information required to develop and deploy generative AI models. According to the U.S. Centers for Disease Control and Prevention (CDC), 95.0% of office-based physicians had adopted EHR systems in 2024. This expanding digital infrastructure is expected to support demand for generative AI solutions during the forecast period.
Data Privacy Concerns and Limited Clinical Validation Hampering Market Growth
The global generative AI in healthcare market outlook remains positive due to increasing adoption of AI-based healthcare solutions, rising investments in drug discovery as well as growing demand for workflow automation. However, data privacy concerns, regulatory challenges, and limited availability of high-quality clinical datasets might slow market growth.
Generative AI systems often process sensitive patient information, including medical histories, diagnostic reports, and treatment records. Any unauthorized access or misuse of such data can create serious privacy and security risks for healthcare organizations. Compliance with healthcare data protection regulations also increases the complexity of deploying these technologies.
The accuracy of AI-generated information is another major concern. AI generative models have a tendency of giving erroneous or inaccurate answers. This may lead to wrong clinical decisions when the outputs of the model are not critically evaluated. Validation of such technology is therefore essential for its utilization in a clinical setting. The high cost of implementation may act as an additional barrier.
Growing Investments in AI-Based Drug Discovery Creating Growth Opportunities
Increasing investments in artificial intelligence-based drug discovery and precision medicine are creating lucrative growth opportunities for market players. Pharmaceutical and biotechnology companies are exploring generative AI to identify drug targets, design new molecules, and improve early-stage research. These technologies can analyze large biological and chemical datasets and help researchers identify promising drug candidates.
For instance, Insilico Medicine announced the nomination of its AI-discovered preclinical candidate ISM0387 in April 2026. The candidate was developed using the company's generative AI platform, Pharma.AI. The development highlights the growing role of generative AI in pharmaceutical research and drug discovery.
Growing collaborations between pharmaceutical companies, biotechnology firms, and AI technology providers are also supporting market expansion. Continued investments in AI-powered research platforms and specialized models are expected to create new opportunities for companies operating in the generative AI in healthcare market.
Immediate Delivery Available | Buy This Premium Research Report:
Emerging Generative AI In Healthcare Market Trends
Increasing adoption of AI-based clinical documentation tools is a key market-shaping trend. Healthcare providers are increasingly using generative AI to prepare clinical notes, summarize patient records as well as automate routine documentation. These tools can help reduce administrative workload and improve access to relevant patient information. Integration with electronic health record systems is further supporting their use across hospitals and healthcare facilities.
Growing development of healthcare-specific AI models is expected to boost market growth during the forecast period. Technology companies are increasingly developing AI models designed for medical applications rather than relying only on general-purpose tools. These models can be adapted using medical literature, clinical guidelines, and healthcare datasets to support applications like clinical documentation, patient record summarization as well as research. Their development is expected to improve the relevance of AI-generated information in healthcare settings.
Rising interest in agentic AI for healthcare workflows is also fostering market growth. Unlike conventional generative AI tools that mainly respond to user prompts, agentic AI systems can coordinate multiple connected tasks. Healthcare organizations are exploring these systems for activities like patient record preparation, appointment scheduling, administrative processing as well as prior authorization workflows. Growing interest in workflow automation is expected to encourage further development of such solutions.
Rising demand for personalized medicine is creating a conducive environment for the expansion of generative AI in healthcare market. Generative AI can analyze patient records, genetic information, medical histories as well as clinical data to support more personalized treatment approaches. Growing interest in precision medicine is encouraging healthcare providers and pharmaceutical companies to explore AI-powered solutions for treatment planning and patient management.
Increasing adoption of AI-powered medical imaging and diagnostics is likely to fuel market growth during the forecast period. Generative AI is increasingly being explored for medical image enhancement, synthetic image generation, image analysis as well as clinical decision support. These applications can help improve the availability of training data and support healthcare professionals in interpreting complex medical information.
Expansion of telehealth and digital healthcare services is expected to create growth avenues for generative AI in healthcare solution providers. Growing use of telemedicine, remote patient monitoring, and digital health platforms is generating demand for intelligent tools that can support patient interactions, summarize consultations, answer routine questions, and assist with care coordination.
Analyst's View
“The global generative AI in healthcare market is expected to witness strong growth as healthcare providers and pharmaceutical companies increasingly adopt AI-based solutions. Growing use of generative AI in clinical documentation, drug discovery, and healthcare workflow automation is creating new opportunities for market participants. Companies focusing on healthcare-specific AI models, data security, and strategic collaborations are likely to strengthen their position in this evolving market,” said a senior analyst at CMI.
Current Events and Their Impact on the Generative AI In Healthcare Market
Tempus AI, Inc.
Abridge AI, Inc.
CONTACT: Mr. Shah
Coherent Market Insights
533 Airport Boulevard,
Suite 400, Burlingame,
CA 94010, United States
US: + 12524771362
UK: +442039578553
AUS: +61-8-7924-7805
India: +91-848-285-0837
Email:...
Comments
No comment